News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Eaton Scientific Systems, Ltd. Engages Cislo & Thomas LLP to Advance Tropine 3 Hot Flash Treatment Patent Application and Intellectual Property Strategy

9/18/2012 10:14:32 AM

BEVERLY HILLS, Calif., Sept. 17, 2012 /PRNewswire/ -- Eaton Scientific Systems, Ltd. ("Eaton" or the "Company") a wholly-owned subsidiary of Pristine Solutions, Inc. (OTCQB: PRTN) is pleased to announce that it has engaged full service intellectual property law firm Cislo & Thomas LLP to advance its Tropine 3 patent application and intellectual property strategy. Tropine 3, is a patent pending novel indication of FDA approved homatropine for non-hormonal treatment of hot flashes in pre-menopausal, peri-menopausal, and post-menopausal women.

"As a rapidly emerging drug development company, we anticipate that we will be required to rely heavily on our intellectual property rights, in particular our potential patents. Working with a well-respected and established intellectual property law firm will be critical to our on-going success," stated Michael Borkowski, CEO of Eaton Scientific. "In the modern drug development business model, a well-crafted and guarded patent is often a company's most crucial asset in a sector that is extremely research-intensive, high risk, and with relatively low imitation costs. We will continue to work closely with the professionals at Cislo & Thomas to ensure Eaton Scientific has a solid IP strategy and maximizes its patent values."

Founded in 1979, Cislo & Thomas LLP is a full service, California-based intellectual property law firm providing patent, trademark, copyright, and trade secret legal services to the business and entertainment communities, both locally and worldwide through a network of associates in every major country of the world. With offices in Santa Monica, Westlake Village, and Santa Barbara, Cislo & Thomas attorneys and paralegals file patents, trademarks, and copyrights, and also use real-world experience in business to effectively litigate these matters in Federal Court.

Each Cislo & Thomas patent attorney is highly trained in various technical disciplines and specialties and are often engineers and scientists in addition to being attorneys admitted to the United States Patent and Trademark Office and the Federal Courts. They are also seasoned attorneys who can handle all forms of intellectual property disputes. This depth has allowed Cislo & Thomas to become one of the top-rated law firms in the nation, as independently rated by Lexis-Nexis Martindale Hubble and The Bar Register of Preeminent Lawyers, which lists Cislo & Thomas in the top 5% of all law firms in the country.

The Company anticipates taking notable steps with regard to its patent portfolio and intellectual property strategy over the coming weeks. Additional information regarding this will be made in subsequent press releases.

About Pristine Solutions, Inc.

Pristine Solutions, Inc., through its wholly-owned subsidiary company, Eaton Scientific Systems, Ltd., holds the intellectual property and global marketing rights to Tropine 3, a patent pending novel indication of an existing FDA approved drug for the non-hormonal treatment of hot flashes in pre-menopausal, peri- menopausal, and post-menopausal women.

Forward-Looking Statements/Disclaimer

Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Pristine Solutions' actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Pristine Solutions' filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Pristine Solutions herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Pristine Solutions disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.

SOURCE Eaton Scientific Systems, Ltd.

Read at

Related News

comments powered by Disqus